Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Has results × Bevacizumab × Clear all

Phase

Status

Sponsor Class

OTHER 298 INDUSTRY 199 NIH 85 NETWORK 15 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1

Interventions

ibritumomab tiuxetan 1 ferric maltol 1 Valganciclovir 1 Tranexamic Acid 1 Tacrolimus 1 Sirolimus 1 Moxibustion 1 Low-Level Light Therapy 1 Infliximab 1 Bevacizumab 1 Alemtuzumab 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01296815 2015-07-27

Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity

Centro de Investigación en. Enfermedades Infecciosas, Mexico

Phase 2 Completed

14 enrolled 7 charts

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡